Oncogenic ?-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice, Journal of Clinical Investigation, vol.122, issue.2, pp.586-599, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02532857
IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness, Oncotarget, vol.8, issue.46, pp.80235-80248, 2016. ,
Deciphering liver zonation: New insights into the ?-catenin, Tcf4, and HNF4? triad, Hepatology, vol.59, issue.6, pp.2080-2082, 2014. ,
The role of cytokines in hepatocellular carcinoma, Journal of Leukocyte Biology, vol.80, issue.6, pp.1197-1213, 2006. ,
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas, Proc Natl Acad Sci, vol.95, pp.8847-8851, 1998. ,
?Fibrous nests? in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome, The International Journal of Biochemistry & Cell Biology, vol.81, pp.195-207, 2016. ,
Dimensions of hepatocellular carcinoma phenotypic diversity, World Journal of Gastroenterology, vol.24, issue.40, pp.4536-4547, 2018. ,
Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection, Hepatology, vol.66, issue.5, pp.1502-1518, 2017. ,
Inflammatory cytokines promote the retrodifferentiation of tumor?derived hepatocyte?like cells to progenitor cells, Hepatology, vol.60, issue.6, pp.2077-2090, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01134747
, Corrigendum to ?EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma? [J Hepatol 69 (2018) 182?236], Journal of Hepatology, vol.70, issue.4, p.817, 2019.
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016?2030, Journal of Hepatology, vol.69, issue.4, pp.896-904, 2018. ,
United Kingdom, and United States for the period, Journal of hepatology, vol.69, pp.896-904, 2016. ,
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, vol.67, issue.1, pp.123-133, 2017. ,
Hepatocellular carcinoma, The Lancet, vol.391, issue.10127, pp.1301-1314, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01134844
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation, Gastroenterology, vol.152, issue.5, pp.1090-1099.e1, 2017. ,
T-cell factor 4 and ?-catenin chromatin occupancies pattern zonal liver metabolism in mice, Hepatology, vol.59, issue.6, pp.2344-2357, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02532861
Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma, Hepatology, vol.69, issue.1, pp.160-178, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02532127
Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma: Hepatobiliary Malignancies, Hepatology, vol.69, pp.160-178, 2019. ,
The significance of intertumor and intratumor heterogeneity in liver cancer, Experimental & Molecular Medicine, vol.50, issue.1, pp.e416-e416, 2018. ,
Hepatocellular carcinoma, Nature Reviews Disease Primers, vol.2, issue.1, p.16018, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01910322
De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas, Oncotarget, vol.7, issue.26, pp.39026-39043, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01335675
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation, Hepatology, vol.66, issue.5, pp.1377-1380, 2017. ,
Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication, Oncology, vol.92, issue.1, pp.40-49, 2016. ,
Wnt/?-Catenin Signaling, Disease, and Emerging Therapeutic Modalities, Cell, vol.169, issue.6, pp.985-999, 2017. ,
Natural history of liver fibrosis progression in patients with chronic hepatitis C, The Lancet, vol.349, issue.9055, pp.825-832, 1997. ,
HepaRG Cells as Human-Relevant In Vitro Model to Study the Effects of Inflammatory Stimuli on Cytochrome P450 Isoenzymes, Drug Metabolism and Disposition, vol.43, issue.1, pp.119-125, 2014. ,
, Drug Metabolism and Disposition, vol.43, pp.119-125, 2014.
Determination of extracellular matrix collagen fibril architectures and pathological remodeling by polarization dependent second harmonic microscopy, Scientific Reports, vol.7, issue.1, 2017. ,
Chemokine-Induced Macrophage Polarization in Inflammatory Conditions, Frontiers in Immunology, vol.9, p.1, 2018. ,
Necroptosis microenvironment directs lineage commitment in liver cancer, Nature, vol.562, issue.7725, pp.69-75, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02348982
Biopsy for liver cancer: How to balance research needs with evidence-based clinical practice, Hepatology, vol.61, issue.2, pp.433-436, 2015. ,
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets, Nature Genetics, vol.47, issue.5, pp.505-511, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01159736
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features, Gastroenterology, vol.153, issue.3, pp.812-826, 2017. ,
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis, Cell Reports, vol.19, issue.1, pp.203-217, 2017. ,
Wnt-/-?-catenin pathway signaling in human hepatocellular carcinoma, World Journal of Hepatology, vol.7, issue.26, p.2631, 2015. ,
Wnt signalling: conquering complexity, Development, vol.145, issue.12, p.dev165902, 2018. ,
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma, Gastroenterology, vol.149, issue.5, pp.1226-1239.e4, 2015. ,
Differential effects of inactivated Axin1 and activated ?-catenin mutations in human hepatocellular carcinomas, Oncogene, vol.26, issue.5, pp.774-780, 2006. ,